YCBD Earnings Prediction
The chart below shows how YCBD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, YCBD sees a +18.04% change in stock price 10 days leading up to the earnings, and a -8.54% change 10 days following the report. On the earnings day itself, the stock moves by +0.46%. This data can give you a slight idea of what to expect for the next quarter's release.
YCBD Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
5.11M
-4.87%
12.23%
Gross Margin
60.68%
-0.36%
27.64%
Operating Margin
-1.69%
-90.90%
-75.68%
Net Margin
0.30%
101.62%
-108.96%
EPS
-0.22
-67.16%
22.22%
No Data Available
YCBD Earnings Analysis
cbdMD Inc Corporation (YCBD.A) Earnings Conference Call
Positive
Revenue Growth Trend: Revenue rebounded and grew sequentially over the fourth quarter, indicating a positive trend in sales performance.
Strong Gross Margins: Gross margins held strong at 66%, demonstrating the durability of the company's business model.
SG&A Cost Reduction: SG&A costs improved significantly, reflecting disciplined expense management, with expenses reduced from $4.6 million to $3.4 million year-over-year.
Positive EBITDA Milestone: For the first time in company history, cbdMD achieved positive non-GAAP adjusted EBITDA of $214,000, a significant improvement from a loss of $698,000 in the prior year.
Product Innovation in Sleep Aids: The company launched new and enhanced formulations for its sleep and calm products, indicating a commitment to innovation and product improvement.
Oasis Tonic Revenue Potential: The Oasis social tonic line has been well received, with plans for distribution agreements that could significantly enhance revenue opportunities.
Debt-Free Status Benefits: The company is now debt-free, excluding ordinary course liabilities, which frees up cash for working capital and growth initiatives.
Organizational Transformation and Resilience: cbdMD has transformed into a leaner, more disciplined organization, showing resilience and adaptability in a challenging industry.
Negative
Earnings Miss Reported: cbdMD, Inc. reported a significant earnings miss with an EPS of $-216.47, far below the expected $-0.37, indicating ongoing financial struggles.
E-commerce Sales Decline: The e-commerce direct-to-consumer sales decreased by 10% year-over-year, suggesting a decline in customer engagement or market share in this segment.
Sales Growth vs. Operational Loss: Despite a 12% increase in total net sales, the company still reported a loss from operations of approximately $86,000, highlighting ongoing operational challenges.
Working Capital Deficit Concerns: The company has a working capital deficit of approximately $2.8 million, which raises concerns about liquidity and financial stability.
Rising Operating Costs: The anticipated increases in operating costs and marketing expenses may further strain the company's financial resources in the upcoming quarter.
Capital Structure Challenges: The company is still navigating complex challenges related to its capital structure, which poses risks to its long-term success and compliance with NYSE listing standards.
YCBD FAQs
How does YCBD typically perform around its earnings report dates?
Is cbdMD Inc (YCBD) Q1 2025 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
YCBD Earning Call Sentiment
cbdMD, Inc. (AMEX:YCBD) Q1 2025 Earnings Call Transcript
YCBD.A
-10.34%Positive
The earnings report showed mixed signals: a revenue increase and improved net income, but a significant EPS miss and capital restructuring challenges. The Q&A indicated tighter margins and slow wholesale distribution, with management's unclear responses on key metrics. Regulatory compliance issues and shareholder concerns add to the negative sentiment. While there were some positive aspects, such as debt reduction and a slight net income, the overall financial instability and market challenges suggest a negative stock price movement in the near term.
